Tag: ASX

Graphitic materials supplier First Graphene said its collaborative project with Halocell Energy and the Queensland University of Technology to commercialise perovskite solar cell fabrication has received a Cooperative Research Centres Project (CRC-P) grant worth $2 million. 

Australian metal additive manufacturing company Titomic Limited has provided its financial statements for fiscal year 2023, ending with a total revenue of $4.45 million. 

Aerospace composite manufacturer Quickstep has collaborated with the Sovereign Manufacturing Automation for Composites CRC (SoMAC CRC) and Deakin University’s Institute for Intelligent Systems Research and Innovation to help address the high cost of large-scale composite production. 

Aerospace composite manufacturer Quickstep has signed a contract with unmanned aerial vehicle (UAV) developer TB2 to provide engineering and structural integration services for the incorporation of the TB2 Pod Interface system into customer aircraft. 

BlueScope has made a $1.15 billion investment in the relining and upgrade of the No.6 Blast Furnace (6BF) Port Kembla Steelworks and announced a dip in profit in fiscal year 2023. 

Aluminium extruder and distributor Capral Limited has posted its financial report for the first half of 2023, outlining strong results that went beyond expectations. 

ASX-listed IperionX announced the receipt of pivotal development permits for the Titan Project located in Tennessee, which is touted as the United States' most significant JORC-compliant resource of titanium and rare earth-rich mineral sands.

Syrah Resources, an ASX-listed industrial minerals and technology company, has signed a non-binding memorandum of understanding with lithium-ion battery manufacturer Samsung SDI to evaluate natural graphite active anode material (AAM) supply from Syrah’s Vidalia AAM facility in Louisiana in the US. 

Waterco, a global water treatment provider and pool equipment manufacturer, is set to acquire Davey Water Products, a subsidiary of GUD Holdings, for $64.9 million. 

ASX-listed biotechnology company Anteris Technologies has announced the successful use of its DurAVR THV biomimetic valve in a valve-in-valve (ViV) procedure.